Evidence map›Paper›PMID 27342417›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2016

ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.

Haiyan Sun, Christopher G England, Reinier Hernandez, Stephen A Graves, Rebecca L Majewski, Anyanee Kamkaew, Dawei Jiang, Todd E Barnhart, Yunan Yang, Weibo Cai

Open access · greenAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. CD146: a promising target in respiratory diseases.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. CD146-Targeted Multimodal Image-Guided Photoimmunotherapy of Melanoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Article
  12. Antibody-Based Tracers for PET/SPECT Imaging of Chronic Inflammatory Diseases.Chembiochem : a European journal of chemical biology · 2019
    Review
  13. Radiolabelled Aptamers for Theranostic Treatment of Cancer.Pharmaceuticals (Basel, Switzerland) · 2018
    Review
  14. Article
  15. Noninvasive PET Imaging of T cells.Trends in cancer · 2018
    Review
  16. Review
  17. ImmunoPET imaging of tissue factor expression in pancreatic cancer withJournal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  18. Article
  19. ImmunoPET to help stratify patients for targeted therapies and to improve drug development.European journal of nuclear medicine and molecular imaging · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Haiyan Sun *Department of Radiology, University of Wisconsin - Madison, WI 53705, USA.
Christopher G England *Department of Medical Physics, University of Wisconsin - Madison, WI 53705, USA.
Reinier HernandezDepartment of Medical Physics, University of Wisconsin - Madison, WI 53705, USA.
Stephen A GravesDepartment of Medical Physics, University of Wisconsin - Madison, WI 53705, USA.
Rebecca L MajewskiDepartment of Biomedical Engineering, University of Wisconsin - Madison, WI 53705, USA.
Anyanee KamkaewDepartment of Radiology, University of Wisconsin - Madison, WI 53705, USA.
Dawei JiangDepartment of Radiology, University of Wisconsin - Madison, WI 53705, USA.
Todd E BarnhartDepartment of Medical Physics, University of Wisconsin - Madison, WI 53705, USA.
Yunan YangDepartment of Radiology, University of Wisconsin - Madison, WI 53705, USA.
Weibo CaiDepartment of Radiology, University of Wisconsin - Madison, WI 53705, USA.
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
BIOTECHNOLOGY TRAINING PROGRAMT32GM008349 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 1989 to 2019
$22.5M
U.W. RADIOLOGICAL SCIENCES TRAINING PROGRAMT32CA009206 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Bryan Patrick Bednarz · 1985 to 2026
$12.1M
Novel Combination Therapy for Prostate CancerR01CA169365 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI CAI, WEIBO · 2013 to 2015
$903k
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA169365NCI NIH HHS T32 CA009206NIGMS NIH HHS T32 GM008349
6 · The paper itself

Abstract

purposeOverexpression of CD146 in solid tumors has been linked to disease progression, invasion, and metastasis. We describe the generation of a

methodsThe anti-CD146 antibody (YY146) was conjugated to 1,4,7-triazacyclononane-triacetic acid (NOTA) and radiolabeled with

resultsFlow cytometry and western blot studies showed similar findings with H460 and H23 cells showing high levels of expression of CD146. Small differences in CD146 expression levels were found among A549, H4006, H522, and H358 cells. Tumor uptake of

conclusionThe strong correlation between tumor uptake of

Indexed as

AnimalsAntibodies, MonoclonalCD146 AntigenCell Line, TumorCoordination ComplexesFemaleHumansLung NeoplasmsMiceMice, NudeMolecular ImagingPeptidesPositron-Emission TomographyRadiopharmaceuticalsReproducibility of ResultsSensitivity and Specificity64Cu-NOTA-3-4AAntibodies, MonoclonalCD146 AntigenCoordination ComplexesMCAM protein, humanPeptidesRadiopharmaceuticalsCD146Lung cancerMolecular imagingMonoclonal antibodyPositron emission tomography (PET)YY146

Identifiers

PMID27342417
PMCPMC5050101
OpenAlexW2470731587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.